Maryland State Retirement & Pension System’s iTeos Therapeutics ITOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,038
Closed -$137K 1574
2023
Q1
$137K Hold
10,038
﹤0.01% 1505
2022
Q4
$196K Buy
+10,038
New +$196K 0.01% 1458
2022
Q2
Sell
-8,118
Closed -$261K 1512
2022
Q1
$261K Buy
+8,118
New +$295K 0.01% 1387

Other funds holding ITOS

Maryland State Retirement & Pension System's ITOS Position: Q2 2023 in Review

Maryland State Retirement & Pension System sold out of iTeos Therapeutics (ITOS) in Q2 2023, closing a stake of 10,038 shares — an estimated $137K sold.

Maryland State Retirement & Pension System first reported a position in ITOS in Q1 2022 and held it in 3 quarters. The position peaked at $261K in Q1 2022. 146 funds tracked by Wall St. Rank hold ITOS as of Q2 2023.

  • Maryland State Retirement & Pension System reported no remaining iTeos Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Maryland State Retirement & Pension System sold 10,038 iTeos Therapeutics shares in Q2 2023, an estimated $137K.
  • Maryland State Retirement & Pension System first reported a position in iTeos Therapeutics in Q1 2022 and held it in 3 quarters.
  • Maryland State Retirement & Pension System's iTeos Therapeutics position peaked at $261K in Q1 2022.
  • 146 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q2 2023.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2023, filed 11 Jul 2023.